BioXcel Therapeutics Inc (BTAI)
2.71
-0.26
(-8.75%)
USD |
NASDAQ |
Apr 24, 12:50
BioXcel Therapeutics Cash and Short Term Investments (Quarterly): 65.22M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 65.22M |
| September 30, 2023 | 89.96M |
| June 30, 2023 | 127.54M |
| March 31, 2023 | 165.52M |
| December 31, 2022 | 193.72M |
| September 30, 2022 | 232.31M |
| June 30, 2022 | 233.45M |
| March 31, 2022 | 200.44M |
| December 31, 2021 | 232.97M |
| September 30, 2021 | 252.91M |
| June 30, 2021 | 273.06M |
| March 31, 2021 | 194.02M |
| December 31, 2020 | 213.12M |
| Date | Value |
|---|---|
| September 30, 2020 | 233.43M |
| June 30, 2020 | 65.50M |
| March 31, 2020 | 80.08M |
| December 31, 2019 | 32.43M |
| September 30, 2019 | 40.25M |
| June 30, 2019 | 29.96M |
| March 31, 2019 | 36.30M |
| December 31, 2018 | 42.56M |
| September 30, 2018 | 47.12M |
| June 30, 2018 | 50.35M |
| March 31, 2018 | 55.46M |
| December 31, 2017 | 0.887M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
29.96M
Minimum
Jun 2019
273.06M
Maximum
Jun 2021
155.57M
Average
193.72M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Synlogic Inc | 47.75M |
| Cormedix Inc | 76.03M |
| Bristol-Myers Squibb Co | 12.28B |
| Verastem Inc | 137.13M |
| Ocular Therapeutix Inc | 195.81M |